Home Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...
 

Keywords :   


Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...

2015-03-09 12:33:20| Biotech - Topix.net

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a 2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumonia e . SASPject 's PT4 is targeted at E. coli and K. pneumoniae , including multi-drug resistant strains.

Tags: develop award translation therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11
23.11ProjectDIVAF
23.11MtG
23.11THUNDER TRUCKS HOLLOW II 148
23.11 the Tiger 7 EP
23.11 11 LEGACY
23.11 GENOCIDE
23.11HG PART1 PART2
More »